• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES PR FOGARTY ARTERIAL EMBOLECTOMY CATHETER; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES PR FOGARTY ARTERIAL EMBOLECTOMY CATHETER; CATHETER, EMBOLECTOMY Back to Search Results
Model Number 120804FP
Device Problem Material Fragmentation (1261)
Patient Problem Insufficient Information (4580)
Event Type  malfunction  
Manufacturer Narrative
The reported event of defective balloon was confirmed.Balloon latex appeared deteriorated and discolored.Multiple cracks and tears were evident on balloon latex.Leakage was observed through the tears on the balloon.Both balloon windings were intact.Balloon latex was released from proximal winding to check balloon edges at the tears.The edges did not appear to match at the tears.No other visible damage was observed from catheter body.Further evaluation regarding related quality issues is under investigation.Device lot number is either 64311190 or 64394004.For lot 64311190, manufactured date is 21apr2022, expiration date is 18jul2024, and udi is (b)(4).For lot 64394004, manufactured date is 18jun2022, expiration date is 14sept2024, and udi is (b)(4).A device history record review was completed and documented that device met all specifications upon distribution.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis and any excursions above the control limits are assessed and documented as a part of the monthly review.
 
Event Description
It was reported the balloon of an arterial embolectomy catheter was defective.No other additional details were available.Lot number may be either 64311190 or 64394004.
 
Manufacturer Narrative
An engineering evaluation was initiated to assess for any manufacturing related processes which could be correlated to the complaint.A product risk assessment was generated earlier in order to cover the balloons with fragmentations for embolectomy products.Additionally, a capa was generated to address balloons with latex deterioration failure for embolectomy models and is in the implementation phase.Updates to the h6 codes are as follows investigation findings was changed to environment problem identified and investigation conclusions was changed to cause traced to environment.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis and any excursions above the control limits are assessed and documented as a part of the monthly review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FOGARTY ARTERIAL EMBOLECTOMY CATHETER
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
EDWARDS LIFESCIENCES PR
state rd indus pk 402 km 1.4
anasco
Manufacturer (Section G)
EDWARDS LIFESCIENCES PR
state rd indus pk 402 km 1.4
anasco
Manufacturer Contact
jessica atallah
1 edwards way
irvine, CA 92614
MDR Report Key17670392
MDR Text Key322499260
Report Number2015691-2023-15657
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model Number120804FP
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/07/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/14/2023
Initial Date FDA Received09/01/2023
Supplement Dates Manufacturer Received09/01/2023
Supplement Dates FDA Received09/06/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-